Top Markets
Coin of the day
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
株式のランク #14209
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
株価
$12.33
最終同期: 2026-08-31
時価総額
$428.31M
変化(1日)
0.49%
変化(1年)
39.01%
US
取引 Fennec Pharmaceuticals Inc. (FENC)

カテゴリー

Fennec Pharmaceuticals Inc.(FENC)の株式分割履歴
Fennec Pharmaceuticals Inc.株(シンボル:FENC)は合計で0回の株式分割を実施しました。
最新の株式分割はSep 01, 2026に行われました。
Sep 01, 2026より前に購入されたFENC株は、現在0FENC株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH